glp-1 and chronic kidney disease Renal effects of receptor agonists tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine GLP-1 Receptor Agonists and Diabetic

That is a strong statement, but the data backs it up

So Im wondering whether the root cause is actually the motility problem due to some nerves defect that in turn caused the infestation of bacteria in the guts and over time to SIBO

Metformin, for instance, is considered the most reassuring oral agent in terms of congenital risk

These processes not only compromise cellular bioenergetics but also influence immune signaling cascades, such as cGAS-STING and NLRP3 inflammasome pathways, thereby shaping infection outcomes

Eat smaller frequent meals, avoid high-fat foods, stay well-hydrated, and follow the prescribed dose-escalation schedule